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ABSTRACT
This dissertation presents the observations and results 
of an experimental study in embryonated eggs designed to elu­
cidate certain features of the pathogenesis of Diplococcus 
pneumoniae infection combined with influenza C virus. Virus 
infection was initiated by amniotic inoculation and the bac­
terial component was superimposed by amniotic or chorioallantoic 
membrane inoculation. Lethal dose (LD5 0 ) values were calculated 
from cumulative mortality at 96 hours after bacterial inocula­
tion. Preliminary studies for a number of pneumococcus strains 
showed uniformly high cumulative mortality rates indicating 
high potential virulence regardless of the origin of the strains. 
Based on LD50 values determined following combined infection 
with influenza C virus and single infection with pneumococcus 
alone, it is difficult to conclude that established influenza 
infection significantly enhances virulence of the superimposed 
pneumococcus in experimental infection. There was, however, a 
statistically significant increase in mortality in combined in­
fection during the first 24 hours as indicated in the comparison 
of the slope of the percent mortality curves. After this time, 
the percent mortality curves in combined and single infection 
closely approximated each other through 96 hours. In vitro
x
growth curves of pneumococci grown in amniotic fluid from 
virus-infected chick embryos increased significantly during 
the logarithmic phase as compared to that in normal un­
infected amniotic fluid.
Microscopic study of selected embryos revealed an 
absence of discernible inflammatory reaction during the first 
24 hours. From 48 through 96 hours after inoculation inflam­
matory reactions were restricted to the upper and lower 
respiratory tract and consisted of a polymorphonuclear leuko­
cyte infiltration in response to the localization of pneumo­
cocci in the paranasal sinuses, bronchi, alveolar ducts and 
alveolar spaces. Extensive, severe inflammatory reactions 
were more frequently encountered in combined infection. The 
various phases from early exudation to eventual resolution 
which characterize pneumococcal pneumonia in the human host 
were in clear evidence following both the single and combined 
infection of the chick embryo. Although not demonstrated, 
the accumulation of toxic substances, presumably a by-product 
of the reaction of host to the rapidly proliferating parasite, 
was the chief cause of death. The elucidation of the nature 
of these substances awaits further experimental analysis.
xi
INTRODUCTION
The experiments described in the following account were 
undertaken to compare certain aspects of the pathogenesi? of 
combined influenza C virus and pneumococcal infection of 
embryonated eggs with those observed in combined influenza C 
virus and Hemophilus Influenzae which have previously Joeen 
reported from this laboratory. Preliminary studies had in­
dicated that mortality rates were much higher and that com­
parative LD^o values were much more difficult to achieve with 
pneumococci than with H. influenzae. For this reason a num­
ber of pneumococcal strains from various sources was collected 
and the mortality rate resulting from infection with each 
was determined. From these, two strains were selected for 
comparative LD50 determinations and for histopathological 
study.
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REVIEW OF THE LITERATURE 
Clinical knowledge of pneumonia was fairly well estab­
lished by 1838 as a result of the excellent description by 
fiaennec; however, the etiology was neither determined nor 
agreed upon (Heffron, 1939). Klebs in 1875 was probably the 
first to see pneumococci in stained smears of edematous fluid 
from the lungs of patients dying of pneumonia. It was not 
until 1881 that Pasteur and Sternberg simultaneously but in­
dependently reported the culture and isolation from saliva 
of lancet-shaped diplococci which we know today as pneumo­
cocci. These microbes were still not recognized as being 
associated with pneumonia because in each instance they were 
not isolated from clinical cases of pneumonia (White, 1938).
It was in 1884-1885 that Frankel (1886) isolated and des­
cribed the pneumococcus from cases of lobar pneumonia. His 
studies firmly established the etiologic relationship between 
the pneumococcus and lobar pneumonia in man. Frankel's work 
was confirmed a year later by Weichselbaum (1886a,1886b) 
who presented additional findings on the nature of the pneumo­
coccus and named the organism Diplococcus pneumoniae. This 
has remained the accepted designation.
3Man is the reservoir and source of pneumococcal infection 
through secretions from the upper respiratory tract. Trans­
mission is usually by droplet spread acquired as a result of 
direct or close contact with cases or carriers although other 
indirect routes such as fomites have been suspected of play­
ing minor roles. In the United States, cases of pneumonia 
occur sporadically during the winter and spring months, and 
epidemics still occur, especially in institutions and closed 
populations such as those occurring in the military services 
(Gordon, 1965). During viral respiratory epidemics, the in­
cidence of pneumonia due to pneumococci is known to increase 
significantly and generally considered to be the result of 
virus action on the respiratory tract epithelium. In the in­
fant and elderly age groups the highest mortality rates are 
encountered during these epidemics. Other predisposing factors 
to pneumonia include malnutrition, fatigue, exposure and alco­
holism.
It has been estimated that about 50 percent of the so- 
called normal individuals may harbor pneumococci in their 
throats as a part of the overall respiratory microbial flora. 
Usually associated with the pneumococcus and in greater pre­
dominance are found alpha hemolytic streptococci, Neisseria 
species, staphylococci (usually coagulase negative), Hemo­
philus hemolyticus and Hemophilus influenzae (Bailey and Scott,
1970). Generally speaking, the pneumococci comprise but a 
small portion of the microbial flora of the throat; however, 
in some instances particularly In the case of the frank car-
' J
rier, they may represent a sizable portion of the flora.
The majority of cases of lobar pneumonia are caused by 
relatively few serotypes of pneumococcus. Approximately 90 
to 95 percent of the cases are due to Types I, II, III and 
VII and the most severe cases are due to Type III (Robbins,
1967). Other prevalent types include XII, XIV, XVIII, XIX 
and XX. The mortality rate of Type III is about 55 percent, 
but only 15 to 25 percent for the other capsular types. 
Pneumonia remains as one of the major causes of death in the 
United States and hhe pneumococcus accounts for the vast 
majority of cases of acute bacterial pneumonia (Austrian and 
Gold, 1964). Pneumococcal infection may be seen also in 
otitis media, meningitis, peritonitis, arthritis, endocarditis, 
pericarditis and empyema,
Pneumococci are Gram-positive organisms occurring as 
elongate or spherical cocci usually in pairs but sometimes 
in short chains. On blood agar pneumococcal colonies appear 
raised, with elevated concentric rings and a depression at 
the center of the colony (Breed, Murray and Smith, 1957).
All pneumococci show a zone of incomplete or alpha hemolysis 
around the colonies as a result of the in vitro production of
5pneumolysin, an endotoxin related to the 0 hemolysins of 
hemolytic streptococci (Lund,1960; Davis et_ al^,1968). Pneumo­
coccal colonies are encountered in one of three dissociative 
phases, mucoid (M), smooth (S), or rough (R).
Since the genera Streptococcus and Diplococcus are classi­
fied as belonging to the tribe Streptococceae, they share a 
number of common characteristics including microscopic ap­
pearance, gross colony morphology and alpha hemolysis. This 
is particularly true of Streptococcus mitis of the Viridans 
group of streptococci. Although members of the Viridans 
group are quite similar in appearance to pneumococci, they 
can be differentiated on the basis of bile solubility, sensi­
tivity to optochin (ethyl hydrocupreinhydrochloride), and by 
classical demonstration of pneumococcal virulence in mice. 
Pneumococci are sensitive to optochin, bile soluble when 
tested with a 10 percent solution of sodium desoxycholate, 
and are generally uniformly lethal for young mice. Strepto­
cocci, on the other hand, do not share these characteristics.,
Antigenically, the pneumococci contain two main compo­
nents, one capsular and one somatic. The capsular antigenic 
component of the pneumococcus was first described by Neufeld 
in 1902. A few years later, Neufeld and Haendel (1910) pro­
duced a number of monovalent serums against pneumococcal 
isolates and suggested the development of specific serums
against each pneumococcus type. By 1913, Dochez and Gillespie 
had already begun the task of dividing pneumococci into groups. 
At present some 82 specific types and their distinctive anti­
genic formulas are recognized in the serological classification 
of pneumococci (Lund and Rassmussen, 1966). Type specificity 
as a result of the peculiar carbohydrate nature of the pneumo­
coccus capsule was shown to exist as early as 1923 by Heidel- 
berger and Avery. They isolated a specific soluble substance 
(SSS) from Type II pneumococcus and concluded that it was a 
polysaccharide composed of multiple glucose molecules. It was 
the SSS that reacted specifically with protective homologous 
antiserum. Although studied intensively, the chemical struc­
ture of only a few capsular polysaccharide types has been 
established, while the chemical composition is known for many 
of them (Davis et a_l. , 1968) .
That a relationship existed between the polysaccharide 
capsular material and virulence was confirmed by Avery and 
Dubos (1930) in an experiment in which the specific capsular 
polysaccharide of Type III pneumococcus was enzymatically 
hydrolyzed. This capsular loss was reflected by the phago­
cytosis of Type III pneumococci in mouse challenge experiments. 
Phagocytosis did not occur on mouse challenge with control 
cultures of unhydrolyzed capsules indicating that the capsule 
afforded protection.
7The capsule surrounding the cell wall of the pneumococcus 
is perhaps the most striking morphological feature of D. pneumo­
niae . It has been shown by electron microscopy to be composed 
of a hydrophilic gel of low density (Mudd, Heinmets and Anderson, 
1943a and 1943b). In the case of some Type III pneumococcus 
strains there is a surrounding slime layer. Virulence appears 
to be associated at least in part with the quantitative syn­
thesis of specific capsular polysaccharide and the qualitative 
differences in the chemical composition of the specific capsular 
polysaccharide. The relative virulence of pneumococcal strains 
for mice has been further correlated with the amounts of specific 
capsular polysaccharide produced in vitro (MacLeod and Krauss, 
1950). Similar findings with regard to a correlation between 
the quantity of capsule produced and virulence have been re­
ported for Staphylococcus aureus and Klebsiella pneumoniae 
(Ehrenworth and Baer, 1956; Wiley, 1968).
An early cellular defense mechanism called "surface phago­
cytosis" has been shown to occur prior to the appearance of 
opsonizing antibodies and the initiation of opsonin mediated 
phagocytosis. During the early stages of infection surface 
phagocytosis is accomplished by macrophages and polymorphonu­
clear neutrophile (PMN) cells by trapping the pneumococci 
against tissue surfaces and in this manner effecting success­
ful phagocytosis. With highly virulent, encapsulated Type III
pneumococcus the slime layer acts as a defense against surface 
phagocytosis and is unrelated to humoral immunity and may ac­
count for its greater virulence. As in the case of capsular 
polysaccharide, the maximal rates of synthesis for the slime 
layer occurs during the early logarithmic growth phase. A 
sufficient quantity of slime layer produced by the cell is 
required in order to be an effective deterrent to surface 
phagocytosis. This slime layer is lost early during the 
growth phase and leads only a transient existence (Wood and 
Smith, 1947, 1949).
The slime layer has been shown by electron micrographs 
to be a fuzzy extension beyond the capsular limits. Enzymatic 
analysis has revealed it to be the same high molecular weight 
polysaccharide as that of the capsule (Wood and Smith, 1949). 
In vivo studies using Type III pneumococcus (8HCC) have con­
firmed the anti-surface phagocytic role of the slime layer by 
the fact that organisms with capsules and slime layers re­
sisted phagocytosis by polymorphonuclear neutrophils. Once 
the slime layer was lost, surface phagocytosis took place 
readily (Wood and Smith, 1950).
Of the somatically derived antigens one is nucleoprotein 
in nature. It appears to be structurally closely related in 
all pneumococcus types since antibody produced against the 
nucleoprotein of a given type reacts with all the others.
Furthermore, the somatic antigen does not elicit a protec­
tive antibody and the nucleoprotein appears closely related 
to those normally found in Group A beta hemolytic strepto- 
qocci (Austrian and MacLeod, 1949; Smith, Conant and Willet,
1968). The second somatically derived antigen consists of 
two carbohydrate fractions. The first fraction isolated by 
Tillet and Francis in 1930 is designated as Fraction C. It 
is found to be common to all pneumococci and on the basis of 
serologic evidence appeared to be a carbohydrate. Later, Liu 
and Gotschlich (1963) showed by means of acid hydrolysis that 
this C substance contained amino sugars, amino acids, and 
also muramic acid phosphate. These findings indicated a poly­
saccharide nature and cell wall origin. The second fraction 
was designated as F carbohydrate and was shown by Gobel, 
Shedlovsky, Lavin and Adams (1943) to be a lipocarbohydrate 
chemically and immunologically related to C~polysaccharide.
Both the C and F carbohydrate antigens are universally pre­
sent in all pneumococci and do not react with protective anti­
body.
During the course of transformation studies, Taylor (1949) 
reported the recovery of a novel capsular variant which dif­
fered from the serologic type of both the donor and the two- 
step transformant. In similar studies, Beiser and Hotchkiss 
in 1954, isolated and described several strains of pneumococci 
with analogous capsular variants. No serologic relationship
between these strains with capsular variants and any of the 
82 known pneumococcal types has been found. Recently, simi­
lar abnormal capsular polysaccharide has been demonstrated as 
a result of transformation of non-capsulated rough recipient 
cells of Type II pneumococcus with donor desoxyribonucleic acid 
(DNA) from capsulated Type I cells (Bornstein, Schiffman, 
Bernheimer and Austrian, 1968). The capsular polysaccharide 
in this case was designated (Cs) polysaccharide, composed of 
a C-like polysaccharide, and was found on transformed recip­
ient cells which closely resemble the rough recipient colony 
from which they were derived. Additional serologic experi­
ments with the (Cs) polysaccharide have shown that the poly­
saccharide is closely related to C or cell wall pneumococcal 
polysaccharide. Although the exact mechanisms involved in the 
production of (Cs) polysaccharide are not presently known, 
Bornstein et al. feel that these variants may be the result 
of an alteration in the genetic mechanism controlling the ex­
pression of C polysaccharide by depression of the synthesis 
control mechanism for C polysaccharide, by gene duplication, 
or by genetic alteration affecting the linkage of C poly­
saccharide to other cell wall constituents. In any event, 
the Cs variants serve to illustrate further the functional 
complexity of cell wall and surface layers of the pneumococcus. 
The occurrence of Cs variants in nature and their relative
11
importance as a limited survival form over the non-capsulated 
pneumococci remains to be determined.
Uniformity of the biologic characteristics of the pneumo­
coccus is greatly influenced by the environment. This is par­
ticularly true of capsular development. The first studies to 
call attention to variations (dissociations) in morphological 
features and virulence which occurred under artificial con­
ditions were those of Kruse and Pansini (1891). Arkwright 
in 1921 actually established the fact that at least two colony 
types were present in pneumococci and designated these varia­
tions as smooth (S) and rough (R) types. The difference be­
tween S and R colony types was later explained in terms of 
virulence with capsule formation and the ability to elaborate 
specific soluble substances being the determining factors.
The discovery of transformation by Griffith in 1928 laid 
the foundation for establishing the genetic nature of the 
mechanism involved in dissociation. He observed that non­
capsulated avirulent variant strains of Type II R pneumococci 
could be induced by the growth of encapsulated Type III S pneu­
mococci in presence of type specific antiserum. Furthermore, 
these variant non-capsulated strains could on occasion cause 
lethal infection in mice with a recovery of virulent encapsu­
lated Type III S pneumococci. Griffith thought this pheno­
menon was due to a reversion which had taken place with a
12
reinstitution of the synthesis of capsular material as a re­
sult of the presence of sufficient polysaccharide in the in­
jected pneumococcal suspension. To test this idea further, 
he inoculated mice with a suspension containing a small con­
centration of avirulent non-capsulated pneumococci and a heavy 
concentration of heat-killed virulent encapsulated pneumococci. 
Injection of the mixture usually resulted in the death of the 
mice and yielded encapsulated virulent forms while control 
injections with either suspension alone did not result in the 
death of the mice nor in the recovery of encapsulated virulent 
pneumococci. He named this phenomenon "transformation," and 
did not relate these findings to an inheritable trait. He 
did, however, suggest that a specific protein substance which 
mediated the synthesis of specific soluble carbohydrate might 
be involved in the transformation of R pneumococcus or that 
the capsular polysaccharide from the S pneumococcus might 
serve as a mediator in transformation of R pneumococcus.
The importance of Griffith's discovery was not fully 
appreciated until 1944 when Avery, MacLeod and McCarthy,- in 
a systematic chemical study of the transforming substance 
derived from Type III pneumococcus, showed it to be desoxy­
ribonucleic acid (DNA). These findings not only identified 
the transforming principle chemically but also assigned to 
DNA the property of possessing and transmitting genetic
13
characteristics. Prior to this no functional role had been 
assigned to DNA although it had been recognized as being pre­
sent in all living cells (Ravin, 1961).
Genetic transformation studies followed two main avenues 
of investigation which included the chemical confirmation of 
DNA and its properties and the mechanisms of transformation, 
and ultimately led to the proposal by Watson and Crick (1953) 
that DNA consisted of two polynucleotide chains arranged in a 
double helix joined together by hydrogen bonds between the 
nucleotide bases.
The insertion of segments of transforming DNA into the 
genome of the transformable (recipient) cell with either strand 
of donor DNA being effective appears to be the actual mechanism 
of pneumococcal transformation (Avery, MacLeod and McCarthy,
1944; Fox and Allen, 1964). A number of other factors such as 
the importance of choline in the macromolecular structure of 
the pneumococcal cell wall and its influence on competence, 
i.e., the receptiveness of a cell to transformation; and the pre­
sence of a proteinaceous inducer substance, the so-called 
"activator" which is evidently required by incompetent cells 
prior to conversion to competence are additional factors which 
operate in this phenomenon (Thomasz, 1968, 1969).
From the preceding it is evident that all of the charac­
teristics discussed can be influenced or controlled by trans-
formation and may become manifest by one of a myriad of pheno­
typic variants possible with the pneumococcus. Considering 
a single transformable feature such as the capsular polysac­
charide, a novel binary capsulation has been reported (Austrian 
and Bernheimer, 1959). This binary form has a mixture of two 
unitypic polysaccharide antigens in its makeup representing 
the donor and the recipient capsular forms. The biosynthetic 
mechanisms for binary capsulation have been examined and found 
to be a condition in which two competitive metabolic pathways 
exist simultaneously and compete for available uridine dipho­
sphate glucuronic acid (UDPGA) (Austrian, Bernheimer, Smith 
and Mills, 1959). The binary features of these strains (SI- 
III) are relatively unstable and the SI genome is lost quite 
readily (Bernheimer and Wermundsen, 1969). The significance 
of binary capsulation in nature must still be determined.
The role of the pneumococcal slime layer and polysaccha­
ride capsule in virulence has been discussed. Changes in 
these two morphological aspects are usually apparent as popu­
lation changes which may occur in_ vivo or in vitro. There 
are however other more subtle and less easily recognized 
characteristics which may he associated with virulence. 
Neuraminidase (sialidase) activity, for example, has been 
noted with certain strains (Kelly, Greiff and Parmer, 1966). 
Unpublished studies by Kelly and Greiff have shown that in
fatal infections in man and experimental animals, a decrease 
in sialic acid content in the host tissues has been noted on 
histochemical examination. Further data suggest that the 
changes observed histologically are the result of cleavage 
by pneumococcal neuraminidase of the terminal sialic acids 
from glycolipids and glycoproteins which are essential com­
ponents of body tissues. This may cause injury to the cells 
resulting in an alteration at the cell surface which can af­
fect cation transport (Kelly, Farmer and Greiff* 1967). Their 
results further show that all fresh strains isolated from ac­
tive pneumococcal infection have neuraminidase activity. As 
with capsular formation and other factors associated with 
virulence, neuraminidase activity was found primarily during 
the early growth phase of the pneumococci. Smith (1968) has 
suggested that changes in metabolism of pathogenic bacteria 
in vivo may also affect the overall virulence of the organism. 
It has not been easy to study these in vivo mediated metabolic 
changes.
The pathogenesis of pneumococcal pneumonia appears to be 
primarily a function of the virulence of the organism and 
the susceptibility of the host. This acute bacterial infec­
tion in which injury to host tissues takes place requires 
that the pneumococci multiply in sufficient numbers to estab­
lish infection. In order to achieve this the pneumococcus must
16
remain extracellular and evade phagocytosis so that adequate 
multiplication can take place. This is perhaps the most crit­
ical stage in pneumococcal pneumonia as well as in many other 
acute bacterial infections (Wood, 1951).
The pneumococcus gains entrance to the host by way of the 
respiratory tract. The development of lobar pneumonia follows 
if the majority of organisms escape phagocytosis at least long 
enough to establish themselves. This does not exclude the 
possibility of a bronchial (lobular) pneumonia developing as 
a result of penumococcal infection, for this pattern is fre­
quently encountered. Bronchial pneumonia is distinguished 
from lobar pneumonia by the anatomic distribution of consoli­
dation around the bronchioles usually as an extension of an 
existing bronchitis or bronchiolitis. These foci are often 
distributed along the bronchial tree and are usually bilateral 
and multilobular. If the pathologic process is allowed to 
continue, an entire lobe may be involved with confluent consoli­
dation. Histologically, polymorphonuclear neutrophiles (PMN) 
and some fibrin comprise the suppurative exudate which fills 
the bronchi, bronchioles and alveolar spaces (Robbins, 1967).
More than 90 percent of the cases of lobar pneumonia are 
caused by pneumococcal infection. Since this is the most com­
mon pathological pattern with pneumococcus, the principal 
events will be discussed in greater detail in order to clarify
17
the role of the microorganism and the host response in pneumo­
nia. When sufficient numbers of pneumococci have multiplied 
and escaped phagocytosis in the alveolar spaces, a critical 
phase in the infection tabes place in which "surface phagocyto­
sis" by PMN leukocytes occurs prior to the appearance of 
specific opsonins. If successful, resolution takes place as a 
result of this phagocytic activity initiated during the first 
24 hours after infection. The characteristic inflammatory pro­
cess begins whenever the early defense mechanism fails to con­
tain the invading microorganisms. The first stage of congestion 
is accompanied by massive edema with the edema fluid providing 
a rich medium for rapid pneumococcal proliferation. Wood (1951) 
has described the progression of the lesion in the lungs of labo­
ratory rats as consisting of four zones. At the periphery or 
advancing edge of the lesion is located the zone of edema in 
which edema-filled alveolar spaces are found containing numerous 
pneumococci. Next to the advancing edge is the zone of early 
consolidation where numerous pneumococci are present and only 
a minimum of phagocytosis by the PMN leukocytes has taken place. 
Surrounding the central portion of the lesion is the zone of 
advanced consolidation in which the alveolar spaces are filled 
with a closely packed exudate of PMN leukocytes which have 
phagocytized the pneumococci present. In the central portion 
of the lesion macrophage activity is pronounced with clearing
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of the exudate. This is the zone of resolution.
The actual spread of the pneumococcal infection to other 
parts of the lung is by way of infected edematous fluid pro­
duced by the lung vascular system as a result of a delayed- 
type hypersensitivity to the pneumococcus microorganism. The 
infected edematous fluid accumulates in the bronchi communi­
cating with the lesion and in this manner infects other lobes, 
or the fluid may communicate with other uninfected alveoli by 
way of the inter-alveolar pores of Cohn (Wood, 1951).
Following consolidation there is the stage of red hepatiza­
tion which is marked by an outpouring of PMN leukocytes and red 
blood cells extravasated from the capillaries or resulting from 
injury to the alveolar walls. Red hepatization is primarily 
located in the zone of early consolidation of the pneumococcal 
pulmonary lesion.
Gray hepatization follows next in classical lobar pneumonia. 
In this stage there is marked fibrin deposition with PMN leuko­
cyte and red blood cell breakdown and disintegration. Micro­
scopically, a clear zone adjacent to the alveolar wall is noted. 
Alveolar macrophage activity is apparent in these areas. Gray 
hepatization may be followed by complete resolution within 
about 2 weeks with no evidence of inflammation. In some cases 
complications may develop such as pleuritis, empyema, lung 
abscess, or organization of the exudate in alveolar spaces.
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Both of the stages, gray hepatization and resolution are seen 
in the zone of resolution of the pulmonary lesion.
The mechanisms of pneumococcus infection and recovery are 
complex since we are dealing with an organism which as far as 
is known produces no toxic substance which plays a role in 
pathogenesis. Instead, the pathogenic pneumococcus relies on 
its virulence and invasiveness combined with reduced resistance 
on the part of the host to produce acute pneumococcal infection. 
This combination of features is best exemplified by the re­
lationship between influenza virus infection and secondary 
complicating acute bacterial pneumonia. The existence of this 
synergism has been recognized in many influenza outbreaks.
The bacterial agents most commonly associated with this have 
been pneumococci and staphylococci. The occurrence of compli­
cations due to one or the other of these bacteria during res­
piratory virus epidemics is largely determined by their regional 
or local predominance. In some cases pneumococci prevailed, 
while in others, staphylococcal pneumonias were commonly seen.
The first conclusive proof of a pathogenic correlation 
between previously established virus infection followed by 
bacterial infection was demonstrated by Shope (1931) with 
swine influenza virus and Hemophilus influenzae suis as the 
cause of severe illness in swine. A few years later, Elkeles 
(1935) demonstrated the susceptibility of swine to human
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influenza virus. This was followed by an unsuccessful attempt 
to establish a definite pathogenic correlation in swine between 
human influenza virus and H. influenzae (Mote and Fothergill, 
1940).
The first use of the chick embryo in the study of this 
kind of synergism was reported by Bang (1943). In his studies 
the chick embryo was shown to be a highly sensitive model for 
demonstrating synergism between swine influenza virus and H. 
influenzae suis in combined infection. Comparative studies 
by Janssen (1960) and Janssen, Chappell and Gerone (1963) on 
the synergistic activity between PR8 influenza virus and 
Staphylococcus aureus in guinea pigs and in embryonated eggs 
also verified the greater sensitivity of the embryonated egg. 
Combined infection with influenza A (Asian strain) virus and 
staphylococcus has also been studied in the embryonated egg 
model (Cook, Francis and Kendrick, 1961).
The suitability of the chick embryo as an experimental 
model for the study of the dynamics of bacterial infection has 
been shown in a number of studies conducted in this laboratory 
(Buddingh, 1956, 1963; Buddingh, Al-Talib and Pipes, 1966). To 
the author's knowledge, the only other reported studies with 
the pneumococcus in the embryonated egg have been those of 
Knothe (1952). In these studies a -dose-dependent effect was 
shown to exist among the pneumococcus strains studied.
MATERIALS AND METHODS 
Strains of Diplococcus pneumoniae
Of the 10 strains used in this study 7 were isolated 
from routine throat cultures and 1 from the blood of a patient 
with purulent meningitis at Charity Hospital, New Orleans.
One, designated as B 11 was isolated from a case by the USAF 
Epidemiological Laboratory, Lackland AFB, Texas and strain 
6301 of the American Type Culture Collection was a Type I.
Each was identified as D. pneumoniae by bile solubility, opto- 
chin sensitivity and inulin fermentation. By means of posi­
tive reactions in Quellung serums the strains obtained from 
routine throat cultures were identified as follows: strain U 
155, A; G 129, B; I 161, E, Type XIX; W 155, E; S 141, E; I 
52, F; and I 145 untypable rough. Case strains Ruiz and B 11, 
were identified as D Type XIII and B, respectively.
With the exception of strain 6301, all were used within 
five transfers from the original culture. Each strain was 
preserved by inoculating the yolk sac of a 1 0-day embryonated 
egg with 0.1 ml of an 18-hour culture grown in brain heart in­
fusion ( B H I ) ^  broth at pH 7.4 supplemented with one percent
1
Brain infusion broth; Difco Laboratories Inc., Detroit, 
Michigan
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defibrinated sheep red blood cells. The yolk fluid was har­
vested at 24 hours from live and dead embryos and tested for
cultural purity by steaking onto plates containing brain
(2 )heart infusion (BHI) agarv at pH 7.4 supplemented with 10 
percent defibrinated sheep red blood cells. Except for cul­
tures in liquid media incubated aerobically at 37°C, all other 
cultures were incubated at 37°C in candle jars to achieve in­
creased CC>2 tension. Yolk fluid was ampouled in 1 ml quanti­
ties, shell frozen, and stored at -20°C for later use.
With few exceptions, yolk fluid from embryos infected with 
pneumococci proved satisfactory for maintaining a uniform 
source of inoculum as evidenced by the reproducibility of 
LD50 determinations conducted over a period of months. In most 
cases, it was possible to recover pneumococcus strains which 
had been stored in yolk fluid at -20°C for up to 1 year. 
Influenza Virus
Influenza C virus (J.J. strain) was selected as the viral 
component for use in the study of pneumococcus in combined in­
fection with viral influenza. The stock virus consisted of 
bacteriologically sterile pooled amniotic fluid harvested from 
13-day old embryos which had been inoculated 72 hours earlier. 
Hemagglutinin titers were consistently 1:256 or 1:512. The
2----------------------------
Brain heart infusion agar;
Difco Laboratories Inc., Detroit, Michigan
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stock virus suspension (without antibiotics) was stored at 
6 -8°C and used for all inoculations for no longer than 1 week. 
Embryonated Eggs
Fertile hen's eggs from flocks maintained on antibiotic- 
free diets were obtained from the same hatchery throughout the 
course of this investigation. Eggs were incubated at 39°C in 
a regular hatching incubator, candled on the 9th day of in­
cubation, and prepared by the "window" method. After prepara­
tion, the eggs were transferred to a bacteriological incubator 
at 35°C. Just prior to use, all eggs were examined for uniform­
ity of size, abnormal embryos, torn chorioallantoic membranes 
(CAM), or other defects.
Inoculation of Embryonated Eggs
The amniotic route of inoculation was used for the ini­
tiation of influenza C virus infection. Inoculation was 
usually accomplished on the 11th or 12th day of incubation 
using a tuberculin syringe fitted with a 1% inch 24 gauge 
needle and 0.1 ml of an appropriate dilution of the stock virus 
as determined previously by titration.
Both the amniotic and CAM routes of inoculation were used 
with the pneumococcus strains. The CAM inoculation was ac­
complished by using a tuberculin syringe and a % inch 27 
gauge needle to deliver 0.1 ml of appropriate pneumococcus 
dilution to the surface of the CAM.
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Comparison of Virulence of Pneumococcal Strains
Amniotic inoculation of 15-day embryos was used to select 
strains which could be used for satisfactory LD^q determina­
tions in combined and single infections. Ten strains were 
tested for this purpose.
Serial 10-fold dilutions in BHI broth were made of 18 to 
20-hour BHI broth cultures. Only 10~^ and 10“6 dilutions were 
used in the amniotic .inoculation of 15-day embryonated eggs 
in groups of 10 each. The two dilutions were used in 0.1 ml 
amounts and contained approximately 10° to 102 viable organisms 
for each strain as determined by 0.1 ml 1 0-fold dilutions on 
each of three BHI blood agar plates. Embryonated eggs inoc­
ulated in this manner were examined at 24-hour intervals for 
4 days. A sample of amniotic fluid was removed from all dead 
embryos and cultured for pneumococci on BHI blood agar plates. 
Cumulative deaths at 4 days were used to calculate the ratio 
and percent mortality for each of the strains tested. 
Determination of Comparative Lethal Dose 50 (LD5 0 ) Values
Embryonated eggs were inoculated intra-amniotically with 
influenza virus on the 1.1th or 12th day of incubation or 48 
hours prior to inoculation with pneumococci. Virus-infected 
eggs were separated into groups of 10 each and inoculated 
with serial 1 0-fold dilutions of an 18 to 2 0 -hour broth cul­
ture ..of pneumococcus and incubated at 35°C. The dilutions
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inoculated were initially 10  ^through 1 0”^; however, this 
range was eventually narrowed to include two dilutions above 
and below the approximate LD^q value as determined by inspec­
tion. These embryonated eggs were used to study combined 
viral and bacterial infection. A group of 10 virus-infected 
embryonated eggs served as a virus-infected control.
The same procedures were used for demonstration of the 
effects of single infection with pneumococci in embryonated 
eggs. When at all possible, the same dilution of virus and 
pneumococcus suspension was used in each experimental series 
of single and combined infection. A group of 10 embryonated 
eggs was included as a normal sham inoculated control.
Inoculated eggs were examined at daily intervals up to 
4 days after inoculation with pneumococci and a sample of 
amniotic fluid was aspirated from each dead embryo. The fluid 
was cultured for the presence of pneumococci on BHI blood agar. 
Cumulative deaths through 4 days after inoculation and the 
numbers of viable organisms as determined by titration were 
used in the calculation of LD^q values by the method of Reed 
and Muench (1938).
Determination of Growth Rates of Pneumococcus in Normal 
Amniotic Fluid and in Amniotic Fluid from Influenza £  Virus- 
Infected Embryonated Eggs
In vitro growth of pneumococcus strain I 161 was deter-
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mined in amniotic fluids representing the pooled harvest 
from 12 to 16 embryonated eggs. The embryonated eggs were 
14 days old at the time of harvest and the amniotic fluid 
from the virus-infected embryos was collected from embryo­
nated eggs which had been infected 72 hours earlier with 
influenza C virus. The methods used to infect the embryo­
nated eggs have been described previously.
One-tenth milliliter of an 18 to 20-hour broth culture 
of pneumococcus (1 0  ^viable cells/ml) was used to inoculate 
a 50 ml flash containing 5 ml of amniotic fluid equilibrated 
to 36°C. Both viral infected and normal amniotic fluid were 
tested concurrently. Each inoculated suspension was mixed 
thoroughly and immediately sampled by removing 0.1 ml and 
serially diluting in 1 0-fold increments so that triplicate 
plating of 0.1 ml aliquots of a given dilution would yield 
30 to 300 colonies per plate. This initial count served as 
a baseline.
The flasks were incubated in a reciprocating shaker 
water bath (Model RW 650, New Brunswick Scientific Company, 
New Jersey) at 36°C. Aliquots were sampled and bacterial 
counts determined at 2, 4, 6 , 8 , 10 and 12 hours.
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Determination of the Cumulative Number and Percent Mortality 
in Embryonated Eggs in Combined (Viral-Bacterial) and in 
Single (Bacterial) Infection
Virus infection of 12-day embryonated eggs was ac­
complished as described under inoculation of embryonated 
eggs. Except for one experiment, equal numbers of virus- 
infected and normal 14-day embryonated eggs were selected 
for study. The amniotic route was used for the inoculation
of embryonated eggs with pneumococci and virus as described
— spreviously. A 0.1 ml inoculum of a 10 dilution of an 18 
to 24-hour BHI broth culture of pneumococcus was used to 
inoculate normal and virus-infected embryonated eggs. Sham 
inoculated controls and virus-infected controls were in­
cluded with each experiment.
Embryonated eggs were examined at 24, 48, 72 and 96 
hours after pneumococcus inoculation. The number of dead 
embryos was recorded and a sample of amniotic fluid was 
aspirated from each and cultured for the presence of pneumo­
cocci on BHI blood agar. All embryos with a positive culture 
of pneumococcus were considered to have died of pneumococcal
f 9
infection and were included in the cumulative mortality 
rate calculations.
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Pathogenesis and Pathology of Pneumococcal Infection in 
Influenza Virus-Infected and Normal Control Embryos
Three consecutive experiments were performed in order 
to ascertain the incidence of blood stream invasion and the 
ocurrence of inflammatory lesions following amniotic in­
oculation with pneumococcus strain I 161. A total of 174 
twelve-day embryos were inoculated intra-amniotically with 
0.1 ml of a 10  ^ dilution of Influenza C, J.J. strain from 
passage 229, 2 30 and 2 31, respectiv 1 . Forty-eight hours 
later 0.1 ml of a 10 dilution yielding approximately 1000 
colonies per plate count was injected intra-amniotically. A 
total of 163 normal uninoculated embryos was injected in the 
same manner. Embryos were sacrificed at the 48, 72 and 96- 
hour intervals following inoculation with the pneumococci. 
Cultures were made on BHI blood agar from the amniotic fluid 
and heart blood and each embryo fixed in toto in Zenker's 
fluid (10% acetic acid). After fixation and hardening in 
80% alcohol cross-section blocks in. toto of each embryo were 
cut to include the paranasal sinuses and embryonic lungs and 
processed for sectioning. Sections were routinely stained 
with hematoxylin and eosin and selected ones with Wright's 
stain after the method described by Goodpasture and Anderson 
(1937) .
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Eighteen embryos with combined infection and 18 normal 
controls each at the 48 and 72-hour intervals and 13 with 
combined and 4 normal controls at the 96-hour interval were 
studied in this manner. Thus a total of 5 3 embryos with the 
combined infection and 47 normal controls was studied in this 
manner.
L Form Induction Studies
In vitro induction of L forms from pneumococci was
undertaken using essentially the methods described by Madoff
and Dienes (1958). An 18 to 24-hour broth culture of pneumo-
coccus containing approximately 10 viable cells/ml was used
to inoculate L form media prepared as follows: 4 grams of
( 3)trypticase soy agar ' dissolved in 100 distilled water,
o
autoclaved at 121 C for 15 minutes, cooled to approximately 
56°C and 10 ml discarded. To this medium was added 3 ml of 
packed defibrinated horse red blood cells, 60 ml of filter 
sterilized solution of 40 percent sucrose, 1 percent
(4)
MgS0 4 .7H 2 0 , and 15 ml of sterile horse serum (PPLO free)
This medium was poured approximately 25 ml/petri dish. Sodium 
(S)
penicillin "G" assayed at 1650 units/mg was used as a
3 ------------------------
Trypticase soy agar; Baltimore Biological Laboratory
Division of Becton, Dickinson and Company, Cockeysville,
^Maryland.
Horse serum; Robbin Laboratories, Inc., Chapel Hill, N.C. 
^Sodium penicillin "G"; Nutritional Biochemical Corporation, 
Cleveland, Ohio.
standard source of penicillin. Appropriate quantities of 
penicillin were weighed, added to distilled water and filter 
sterilized. Solutions containing graded concentrations of 
penicillin were incorporated into the cooling L form media 
prior to pouring plates or were used to deposit appropriate 
concentrations of penicillin into precut "troughs" of the 
L form medium plates. Concentrations of penicillin used 
included increments ranging from 0.1 unit/ml to 0.3 unit/ml 
and 0.5, 1, 5, 10, 25, 50, 100, 500 and 1000 unit concentra­
tions. Controls were included with each experimental series 
and consisted of pneumococcus test strains inoculated on L 
form media without penicillin. These controls also served 
as a comparison of colony morphology against the same pneumo­
coccus strain on L form media with penicillin. All inoculated 
plates were incubated at 37°C under CO2 tension in candle 
jars. Plates were examined for L form-like colonies at 24- 
hour intervals for 5 to 7 days. Suspicious colonies, or in 
some cases "swarm" areas, were transferred to fresh plates 
containing L form media and penicillin at an appropriate con­
centration. Agar block transfers v/ere made by removing a 
small block of agar on which L form-like colonies were ob­
served, placing the agar block face down on a fresh plate of 
medium, and pushing the block over the agar surface to obtain 
isolated colonies.
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Experiments were also undertaken to obtain L forms 
through the induction of pneumococcal protoplasts as out­
lined in the methods used by Mauney (1966). Heart infusion 
b r o t h a t  pH 7.4, supplemented with 0.01 percent defibri­
nated sheep red blood cells, was used as the growth medium 
for pneumococci. A 120 ml flask containing 50 ml of the
g
growth medium was inoculated with approximately 10 cells 
and incubated on a reciprocating shaker v/ater bath at 36°C. 
Measurements of pH were made periodically and the cultures 
were harvested when the pH reached 6.0. The cultures were 
centrifuged at 1000 x gravity in a refrigerated centrifuge 
and washed three times with cold sterile 0.9 percent NaCl 
solution, pH 6.0. The washed cells were resuspended in 
sterile 0.2 M sodium phosphate buffer with 0.6 M sucrose at 
pH 6.0 and incubated for 60 minutes at 37°C. Aliquots were 
removed at 2 0 -minute intervals and plated on L form media.
In vivo conversion of pneumococci to L forms was also 
attempted in 12 and 15-day embryonated eggs using amniotic 
and CAM routes of infection. Approximately 106 pneumococci 
were used to inoculate each embryonated egg followed within 
18 to 24 hours by the administration of penicillin by the
6
Heart infusion broth; Difco Laboratories Inc., Detroit, 
Michigan.
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CAM route in concentrations of 1, 10, 100 and 1000 units 
per embryonated egg. Amniotic fluid was aspirated from the 
embryonated eggs just prior to the administration of penicil­
lin to determine the presence of pneumococci. Amniotic fluid 
from all live embryonated eggs was checked at 24-hour in­
tervals for the presence of pneumococcus L forms by culturing 
on L form media and sheep blood agar. In certain experiments 
embryonated eggs were sacrificed at 24, 48 and 96 hours after 
the administration of penicillin, and the amniotic fluid and 
heart blood cultured on L form media and sheep blood agar.
All cultures were incubated under C02 tension at 37°C and 
those for L form culture were incubated for 5 to 7 days. 
Cultures were examined at daily intervals for classical 
pneumococcal and L form colonies. Smears for microscopic 
examination were prepared from L form-like colonies and 
stained using the method of Dienes (1939).
Statistical Analysis of Data
Comparison of the LD50 values in single and combined 
infection found in Tables 2, 3 and 4 was statistically 
analyzed by estimating the LD50 values by the Spearman- 
K&rber method and constructing the confidence intervals at 
the 95 percent confidence level (McMahan, 1967). The statis­
tical analysis of data concerned with the cumulative mor­
tality of embryonated eggs in single and combined infection
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at 24, 48, 72 and 96 hours was accomplished by the paired 
t test method. Data from 3 separate experiments and com­
bined data of the separate experiments was compared by cal­
culation of the best estimate of the slope of a line 
representing the cumulative deaths in single and combined 
infection. A comparison of the slopes representing single 
and combined infection at the 95 percent confidence level 
was used to determine statistical validity. A comparison 
was also accomplished by the paired t test method on four 
individual experiments used in determining the in vitro 
growth rate of pneumococcus in norma], amniotic fluid and in 
amniotic fluid from influenza virus-infected embryonated 
eggs.
OBSERVATIONS AND RESULTS 
Comparative mortality ratios and percent mortality produced 
by ten strains of pneumococci.
The cumulative mortality ratio used to calculate percent
mortality reflected the relative virulence of the strains
compared in this manner (Table 1). High mortality rates were
produced by the majority of strains when inocula yielding 
1 21.54 x 10 to 1.34 x 10 colonies were used. Mortality ranged 
from 88 percent with strain G 129 to 100 percent in the case 
of strains W 155 and B 11. For strain I 161 and Ruiz, mor­
tality rates were 18 percent and 58 percent, respectively.
Eight strains effecting percent mortalities ranging from 
88 to 100 percent were highly lethal within 48 hours after in­
oculation. Ninety-one or 73 percent of a total of 124 embryo 
deaths occurred during this time interval. Of these, 31 oc­
curred during the first 24-hour period, while there were 60 
deaths during the 24 to 48-hour period. Only 30 embryos died 
during the 48 to 96-hour period of which 23 succumbed between 
48 and 72 hours. With strains I 161 and Ruiz deaths occurred 
sporadically with six of a total of nine deaths occurring 
between 72 and 96 hours after inoculation.
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Table 1. Cumulative Mortality Ratios and Percent Mortality 
Produced by Ten Strains of Diplococcus pneumoniae 
in 15-Day Embryonated Eggs.
Strain
Serologic
pool
Number of pneumococci 
in inoculum
Morta
Ratio
lity
Percent
6301 A(I) +
1.34xl02 ( 9/10)** 
1.34X101 ( 6/10)
15/16
6/11
94
55
U 155 A 3X101 ( 9/10) 3x10° ( 8/10)
17/18
3/11
94
27
B 11 B
5.8 xlO1 (10/10)
5.8 xl0° ( 9/10)
19/19
9/10
100
90
G 129 B
2.9 xlO1 ( 8/10)
2.9 xl0° ( 6/10)
14/16
6/12
88
50
Ruiz D(XIII) 3X101 ( 5/10) 
3x10° ( 2/10)
7/12
2/15
58
13
I 161 E(XIX) 5.3 xlO1 ( 1/10)
5.3 xl0° ( 1/10)
2/11
1/19
18
5
W 155 E 1.13X101 (10/10) 1.13x10° ( 7/10)
17/17
3/10
100
33
S 141 E 1.54X101 ( 9/10) 1.54x10° ( 8/10)
17/18
8/10
94
80
I 52 F
5.1 xlO1 ( 9/10)
5.1 xl0° ( 4/10)
13/14
4/11
93
36
I 145 Rough 2.6 xlO1 ( 8/10)
2.6 xl0° ( 9/10)
17/19
9/12
89
75
* Amniotic route of inoculation
Numerator - cumulated deaths at 4 days
*ic Denominator - number of embryos inoculated 
+ Serologic type
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Comparative Lethal Dose 50 (LDgg) determinations of Diplo- 
coccus pneumoniae strain I_ 161 for embryonated eggs with 
established influenza C virus infection and for embryonated 
eggs without virus infection.
LD50 values for CAM inoculation of pneumococcus strain 
I 161 in combined infection with influenza C virus and in 
pneumococcus infection alone are shown (Table 2). The LD50 
values of strain I 161 in three experiments of combined in­
fection were contained in inocula yielding 2 0 ,0 0 0 , 22,000 
and 31,000 colonies with a mean of 24,000. In single infec­
tion, the LD50 values were 15,000, 35,000 and 40,000 colonies 
with a mean of 30,000.
Table 3 presents a summary of the statistical analysis 
of the data presented in Table 2. At the confidence levels 
indicated, the differences between the LD50 values in ex­
periments I and III for combined (C-fP) and single infection 
(P) with pneumococcus only are significant. Experiment II 
shows over-lapping confidence intervals so that differences 
in LD50 values cannot be considered statistically signifi­
cant.
Table 2. Comparative LD^q Determinations of Diplococcus pneumoniae Strain I 161 
for 12 to 13-Day Embryonated Eggs with Established Influenza C Virus 
Infection and for 12 to 13-Day Embryonated Eggs without Virus Infec­
tion Calculated from the Cumulated Deaths 4 Days Following Inoculation.
Exp.
No.
II
III
Inoculum
Influenza 
C Virus 
and 
Pneumo- 
coccus
Number of pneumococci in inoculum*
8xl06 8xl05 8xl04 8xl03 8xl02 8X101
4/10** 5/10 4/10 5/10 0/10 3/10
7.7xl06 7.7xl05 7.7xl04 7.7xl03 7.7xl02 7.7X101
5/10 6/10 3/10 3/10 1/10 4/10
7xl06 7xl05 7xl04 7xl03 7xl02 7X101
5/10 5/10 1/10 1/10 1/10 2/10
8xl06 8xl05
48x10 8xl03 8xl02 8X101
4/10 5/10 3/10 3/10 0/10 3/10
7.7xl06 7.7xl05 7.7xl04 7.7xl03 7.7xl02 7.7X101
6/10 8/10 3/10 4/10 1/10 3/10
3.9xl05 3.9xl04 3.9xl03 3.9xl02 3.9X101
5/10 4/10 3/10 4/10 2/10
LD50
20,000
31,000
22,000
II
III
Pneumo-
coccus
only
40,000
15,000
35,000
*Chorioallantoic membrane route of inoculation
**Numerator - cumulated deaths at 4 days 
**Denominator - number of embryos inoculated
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Table 3. Summary of the Statistical Analysis of Three 
Experiments to Determine the Comparative LD50 
of Diplococcus pneumoniae Strain I 161 for 
12 to 13-Day Embryonated Eggs with Established 
Influenza C Virus Infection (C+P) and for 12 
to 13-Day Embryonated Eggs without Virus 
Infection (P).
Experiment number 
with type of 
infection
Log.LD50 
T value 1
+ H3 • 95
I C+P 5.3030 5.1708 to 5.4352
I P 5.6030 5.4753 to 5.7307
II C+P 4.9865 4.8532 to 5.1198
II P 4.8860 4.7583 to 5.0137
III C+P 5.8451 5.7418 to 5.9484
III p 4.2910 4.1688 to 4.4132
Log. LD^q T value = logarithm of the estimated true LD^q
value as calculated by the Spearman-K&rber method. 
+_ T.95 = confidence intervals at the 95 percent confidence 
level.
Examination of the mortality rate following CAM inocula­
tion in the experiments presented in Table 2 reveals that a 
total of 61 deaths (33.8 percent) occurred among 180 embryo­
nated eggs used in determining LD^g values for combined in­
fection with influenza C virus. Of these, 39 (63.9 percent) 
died between 24 and 48 hours after inoculation. The remain­
ing 22 deaths were nearly equally divided during the 3 sub­
sequent 24-hour intervals preceding 24, 72 and 96 hours. In 
single infection with pneumococcus only, a total of 55 deaths 
(32.4 percent) of 170 embryonated eggr occurred. Twenty-three 
embryos (41.8 percent) died between 24 and 48 hours after in­
oculation. The remaining 32 deaths were nearly equally divided 
during the 3 subsequent 24-hour intervals preceding 24, 72 
and 96 hoursw
LD50 values for amniotic inoculation of pneumococcus 
strain I 161 in combined and single infection are presented in 
Table 4. The LD^g values for combined infection were obtained 
with inocula of 20, 67 and 150 with a mean of 79 colonies, 
while for infection with bacteria only the values were obtained 
with inocula yielding 32, 50 and 58 with a mean of 47 colonies. 
Table 5 presents a summary of the statistical analysis. The 
differences noted in the LD5g values (Table 4) between com­
bined and single infection in experiment I and1II are signi- 
cant while the differences noted in;experiment III are not 
statistically significant.
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Table 4. Comparative LDgg Determinations of Diplococcus 
pneumoniae Strain I 161 for 14-Day Embryonated 
Eggs with Established Influenza C Virus Infection 
and for 14-Day Embryonated Eggs without Virus 
Infection Calculated from the Cumulated Deaths 
4 Days Following Inoculation.
Exp.
No. Inoculum Number of pneumococci in inoculum* LD50
T 9.6xl0 3 9.6xl0 2 9.6X101 9.6x10° 67
Influenza 10/10** 9/10 7/10 4/10
ii
C Virus 
and 5.7xl03 5.7xl02 5.7X101 5.7x10° 150
Pneumo­ 10/10 7/10 5/10 1/10
h i
coccus
6 .8xl0 3 6 .8xl0 2 6.8X101 6 .8x10° 20
10/10 9/10 7/10 6/10
T 6xl0 3 6x 10 6X101 6x10° 58
3/10 6/10 9/10 5/10
II
Pneumo- 5.5xl03 5.5xl02 5.5X101 5.5x10° 50
coccus
only
9/10 9/10 6/10 5/10
III 4.4xl03 4.4xl02
4.4x10^" 4.4x10° 32
10/10 9/10 6/10 6/10
* Amniotic route of inoculation
** Numerator - cumulated deaths at 4 days 
** Denominator - number of embryos inoculated
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Table 5. Summary of the Statistical Analysis of Three 
Experiments to Determine the Comparative LDcjq 
of Dlplococcus pneumoniae Strain I 161 for 
14-Day Embryonated Eggs with Established 
Influenza C Virus Infection (C+P) and for 
Embryonated Eggs without Virus Infection (P).
Experiment number 
with type of infection
Log LDcjo 
T Value
+ T. 95
I C+P 1.5224 1.4624 to 1.5824
I P 2.2782 2.1905 to 2.3659
II C+P 1.9559 1.8948 to 2.0170
II p 1.3404 1.2660 to 1.4148
III C+P 1.1325 1.0725 to 1.1925
III P 1.0425 1.0425 to 1.1058
Log. LDcjq T value - logarithm of the estimated true LD50
value as calculated by the Spearman-K&rber
method.
+T.95 = confidence intervals at the 95 percent confidence 
level„
Table 4 presents a cumulative mortality of 85 deaths 
(70.8 percent) among the 120 embryonated eggs used to de­
termine the LDcjq values in combined infection. The largest 
number, 31 (36.5 percent) of a total of 85 deaths, occurred 
in combined infection between 24 and 48 hours after inocula­
tion. Most of the. reran in ing deaths (43 of 54) occurred 
during the first 24 hours and between 48 and 72 hours after
7
inoculation. With pneumococci alone, the cumulative mortality 
was 92 (76.7 percent) of 120 embryonated eggs inoculated. 
Forty-nine (56.5 percent) of the deaths occurred between 24 
and 48 hours after inoculation with pneumococci while 37 of
the remaining 43 deaths occurred during the first 24 hours 
and between 48 and 72 hours after inoculation.
Comparative Lethal Dose 50 (LD^q ) determinations of Diplococcus 
pneumoniae strain Ruiz for embryonated eggs with established 
influenza C virus infection and for embryonated eggs without 
virus infection.
The LD^q values for combined and single infection with 
pneumococcus strain Ruiz are shown (Table 6 ). In combined 
infection with influenza C virus, the LD50 was contained in 
inocula yielding 7, 3 and 3 colonies in three separate ex­
periments. With pneumococci alone the LDgg values were con­
tained in inocula yielding colony counts of 26, 27 and 40 
with a mean of 31. Statistical analysis of the differences 
noted in the LD^q values for strain Ruiz in combined and 
single infection are given (Table 7). The confidence inter­
vals for experiments I, II and III indicate significant dif­
ferences between the LD50 values in combined infection as 
compared to single infection with pneumococci alone.
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Table 6 . Comparative LD^q Determinations of Diplococcus
pneumoniae Strain Ruiz for 14-Day Embryonated Eggs 
with Established Influenza C Virus Infection and 
for 14-Day Embryonated Eggs without Virus Infec­
tion Calculated from the Cumulated Deaths 4 Days 
Following Inoculation.
Exp.
No.
Inoculum Number of pneumococci in inoculum* LD50
I 4.2xl02 4.2X101 4.2x10° < 1 3
Influenza 9/10** 10/10 9/10 4/10
II
C Virus 
and 
Pneumo-
8 .8xl0 2
1
8 .8x 10 8 .8x 10° < 1 7
10/10 10/10 6/10 3/10
III
coccus
7xl02 7X101 7x10° < 1
10/10 10/10 7/10 4/10 3
4.2xl0 2 4.2X101 4.2x10° < 1 26
I
Pneumo- 10/10 9/10 2/10 0/10
II
coccus
only 8 .8xl0 2 
9/10
8 .8x 10^ 
9/10
8 .8x 10°
3/10
< 1
2/10
40
III
3.6xl02
10/10
3.6X101
7/10
3.6x10°
3/10
27
* Amniotic route of inoculation
** Numerator - cumulated deaths at 4 days 
** Denominator - number of embryos inoculated
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Table 7. Summary of the Statistical Analysis of Three 
Experiments to Determine the Comparative LD50 
Determinations of Diplococcus pneumoniae Strain 
Ruiz for 13-Day Embryonated Eggs with Established 
Influenza C Virus Infection (C+P) and for 13-Day 
Embryonated Eggs without Virus Infection (P).
Experiment number 
with type of infection
Log.LD50
T value 1+ y-
3
• 95
I C+P 0.0768 -0.0589 to -0.1038
I P 1.0510 ' 0.9954 to 1.0510
II C+P 0.5445 0.4945 to 0.5945
II P 1.1445 1.0834 to 1.2056
III C+P 0.2451 0.1951 to 0.2951
III P 1.0551 0.9074 to 1.1028
Log. LD50 T value = logarithm of the estimated true LD50 
value as calculated by the Spearman-KSrber 
method.
+T.95 = confidence intervals at the 95 percent confidence 
level.
As in the previously described experiments, the greatest 
mortality rate 46.7 percent or 43 of a total of 92 deaths oc­
curred between 24 and 48 hours after amniotic inoculation 
with pneumococcus. In all, 78 (84.7 percent) of 92 deaths 
occurred during the first 48 hours. The cumulative percent 
mortality for three experiments of combined infection was 92 
of 120 or 76.6 percent of the embryonated eggs used in deter­
mining the LD^q values. In single infection, the cumulative 
percent mortality was 62 of 110 or 56.3 percent of the embryo­
nated eggs used in three single infection experiments. The 
greatest mortality rate, 32 of 62 or 51.6 percent of the
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deaths, occurred between 24 and 48 hours, and the majority 
of deaths (49 of 62) were recorded during the first 48 hours 
after inoculation.
A few preliminary experiments were conducted with strain 
Ruiz to determine comparative LD^q values for single infec­
tion using 14-day embryonated eggs and CAM inoculation. The
LD50 values were contained in inocula yielding from 2 to 4 
4
x 10 colonies, approximately 3 logarithms higher than those 
obtained by the amniotic route.
Embryonated eggs surviving 4 days after inoculation 
were sacrificed and the amniotic fluid cultured for pneumo­
cocci. Only those embryos inoculated with the LD50 dose or 
greater are reported. With CAM inoculation of pneumococcus 
strain I 161, 47 (22.9 percent) of 205 surviving embryos 
were positive for pneumococci in single infection, and 17 
(26.1 percent) of 65 surviving embryos in combined infection 
with influenza virus. The amniotic route of inoculation of 
I 161 resulted in 26 (42.6 percent) of 61 surviving embryos 
positive for pneumococci in single infection and 27 (61.3
percent) of 44 embryos positive in combined infection. LD50 
determinations for strain Ruiz were confined to the amniotic 
route of inoculation, with 19 (59.3 percent) positive of 32 
surviving embryos in single infection with pneumococcus only 
and 3 (8.3 percent) of 36 embryos in combined infection with 
virus.
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Growth rates of pneumococcus in normal amniotic fluid and 
in amniotic fluid from influenza (2 virus infected embryonated 
eggs.
The results of four experiments are presented as natural 
logarithms representing the mean number of pneumococcal 
colonies which grew out at each time interval (Table 8 ). Pneu­
mococcus growth took place readily in each of the four experi­
ments regardless of whether the experiment was conducted in 
normal or amniotic fluid from virus-infected embryos. The 
input of pneumococci was approximately the same for each 
pair of experiments in normal and virus-infected amniotic 
fluid. The number of colonies at time (tD) zero hours in nor-
mal amniotic fluid ranged from 2.28 x 10-' to 2.8 x 10 /ml 
5
and 2.33 x 10 to 2.8 x 10 /ml in amniotic fluid from virus- 
infected embryos. The numbers of pneumococci in the inoculum 
were comparable for each separate pair of experiments and the 
range did not vary significantly. It should be noted in ex­
periments II, III and IV that determinations at time inter­
vals of 10 and 12 hours indicated that the growth rates 
during the first 8 hours represented the major portion of the 
logarithmic growth phase. With the exception of experiment 
II in virus-infected amniotic fluid, counts at 10 and 12 hours 
indicated a decrease in viable count by a magnitude of one- 
third of a logarithm or greater.
Table 8 . The Mean Logarithm* of the Numbers of Diplococcus pneumoniae Strain 
I 161 at Time Intervals 0, 2, 4, 6 , 8 , 10 and 12 Hours in Normal 
Amniotic Fluid and in Amniotic Fluid from Influenza C Virus-Infected 
Embryonated Eggs.
Time
Hours
Experiment Number
Mean 
N V
I II III IV
N V N V N V N V
0 14.84 14.83 12.33 12.36 14.52 14.61 14.43 14.25 14.03 14.01
2 14.11 14.67 12.56 12.45 14.37 14.90 14.19 14.31 13.81 14.08
4 13.93 14.99 11.61 12.90 14.95 15.18 14.20 14.77 13.67 14.46
6 14.64 14.48 12.45 13.58 16.36 17.54 15.03 16.27 14.62 15.97
8 15.15 16.39 13.17 14.94 16.93 18.35 17.41 18.37 15.67 17.01
10 not run 12.79 15.96 16.40 10.90 17 - 43 17.50 15.56 14.79
12 not run 12.10 17.58 14.73 8.88 14.74 not run 13.86 13.23
* Natural logarithm
N - Normal amniotic fluid from 15-day embryonated eggs
V - Amniotic fluid from 15-day embryonated eggs infected 72 hours earlier 
with Influenza C virus
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Figure 1. Experiment I, in vitro growth curve of D. pneumo­
niae strain I 161 at 0, 2, 4, 6 and 8 hours in 
normal (N) amniotic fluid and in amniotic fluid 
from influenza C virus-infected (V) 15-day embryo­
nated eggs.
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Figure 2. Experiment II, in vitro growth curve of D. pneu­
moniae strain I 161 at 0, 2, 4, 6 and 8 hours in 
normal (N) amniotic fluid and in amniotic fluid 
from influenza C virus-infected (V) 15-day 
embryonated eggs.
50
jS 19i
4 6
Hours
Figure 3. Experiment III, in vitro growth curve of D. pneu­
moniae strain I 161 at 0, 2, 4, 6 and 8 hours in 
normal (N) amniotic fluid and in amniotic fluid 
from influenza C virus-infected (V) 15-day 
embryonated eggs.
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Hours
Figure 4. Experiment IV, iri vitro growth curve of D. pneu­
moniae strain I 161 at 0, 2, 4, 6 and 8 hours in 
normal (N) amniotic fluid and in amniotic fluid 
from influenza C virus-infected (V) 15-day 
embryonated eggs.
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Plots of the growth curves using the natural logarithm 
at 0, 2, 4, 6 and 8 hours are shown (Figures 1-4). Ac­
celerated growth in each of the growth curves as indicated 
by the slope of the line is evident at about 4 hours. Each 
pair of growth curves run in normal and in virus-infected 
amniotic fluid reveals that the growth rate of strain I 161 
is faster in the amniotic fluid from virus-infected embryos. 
This comparison was made by calculating the slope of the line. 
The slope ranged from 0.0581 to 0.3412 in normal amniotic 
fluid and from 0.2514 to 0.5104 in amniotic fluid from virus- 
infected embryos (Table 9). In all instances the slope of 
the line of growth curves in amniotic fluid from virus- 
infected embryos exceeded that of normal amniotic fluid. At 
the 95 percent confidence level, the differences are statis­
tically significant.
Mortality rates for embryonated eggs in combined (viral- 
bacterial) and in single (bacterial) infections.
The experiments with pneumococcus strain I 161 were 
conducted to compare the mortality rates encountered in com­
bined and single infection. These are expressed as cumula­
tive mortality at 24, 48, 72 and 96 hours after inoculation
(Table 10). The inoculum used in each of the paired experi-
1 2ments ranged from 3 x 10 to 1 x 10 . Inspection of the 
cumulative mortality ratios at each time interval shows
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Table 9. A Summary of the Statistical Analysis of Four 
Experiments Determining the In Vitro Growth of 
Diplococcus pneumoniae Strain I 161 in Normal 
Amniotic Fluid and in Amniotic Fluid from In­
fluenza C Virus-Infected 15-Day Embryonated 
Eggs.
Experiment 
no./type
N b + t.95Sb Y SY . X
I/Normal 15 .0581 .0157 to .1005 14.5377 879.6713
I/Viral 15 .2514 .2121 to .2907 15.4529 957.7504
II/Normal 15 .0784 .0451 to .1117 12.4924 759.3101
Il/Viral 15 .3146 .2806 to .3486 13.2438 832.7120
Ill/Normal 15 .3412 .3039 to .3785 15.4275 966.9814
Ill/Viral 15 .5076 .4548 to .5604 16.1181 1028.3700
IV/Normal 15 .3396 .2660 to .4132 15.4275 944.4313
IV/Viral 15 .5104 .4481 to .5727 16.1181 997.2030
N = number of observations
b = slope of the line
jd:.95sb = confidence limits for the slope of the line
Y = mean of the logarithm of the counts for each
observation 
SY.X = standard error of estimate
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Table 10. Cumulative Number and Percent Mortality for 
14-Day Embryonated Eggs with Established In­
fluenza C Virus Infection and Diplococcus 
pneumoniae Strain I 161 and for 14-day Embryo 
nated Eggs without Virus Infection Inoculated 
with Diplococcus pneumoniae Strain I 161.
Exp.
Inoculum Hours aft sr inoculation with pneumococcus*no. 24 48 72 96
I
II
III
Influenza 
C Virus 
and 
Pneumo- 
coccus
8/26**
1/25
12/45
11/26
12/25
20/45
16/26 
2 3/25
42/45
22/26
23/25
45/45
Totals
%
. 21/96
22
43/96
45
81/96
84
90/96
94
I
II
III
Pneumo­
coccus
only
3/26
1/45
2/45
8/26
23/45
5/45
22/26
33/45
23/45
22/26
37/45
34/45
Totals
%
6/116
5
36/116
31
78/116
67
93/116
80
* Amniotic route of inoculation
** Numerator - cumulative deaths at the stated time in­
terval
** Denominator - number of embryos inoculated
IOOi
24 48 72 96
Hours
Figure 5. Cumulative percent mortality in 14-day embryonated 
eggs with established influenza C virus infection 
(C+P) and D. pneumoniae strain I 161 and in 14-day 
embryonated eggs without virus infection inoculated 
with D. pneumoniae strain I 161 (P).
some noticeable variations. A graph showing comparative 
cumulative percent mortality in combined and single infection 
at each 24-hour interval presented (Figure 5). It can be 
seen that the two mortality rate curves closely approximate 
each other in combined (C+P) and single infection (P) except 
for the first 24 hours where the mean mortality rate for 
single infection is 5 percent as compared to 22 percent in 
the case of combined infection. The slope of the curve for 
this time interval was 0.3047 for combined infection and 
0.2553 for single infection. The confidence intervals were 
0.2772 to 0.3322 for combined infection and 0.2336 to 0.2770 
for single infection indicating statistically significant 
differences. Differences in the cumulative mortality rates 
observed at 96 hours are also evident in combined infection 
(90/96 or 94 percent) and in single infection (93/116 or 80 
percent). In other experiments conducted under the same 
experimental conditions' embryonated eggs surviving the first 
24 hours after inoculation with pneumococci were sampled and 
the amniotic fluid cultured. More than 90 percent of the 
embryonated eggs in combined or single infection gave posi­
tive cultures.
Statistical analysis of the two cumulative mortality 
curves indicate that the differences are not significant.
The confidence limits for the slope of the curves in
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combined and single infection were 0.0566 to 0.0996 and 
0.0726 to 0.0998, respectively. Each pair of three combined 
and single infection experiments were statistically analyzed 
and also found to have overlapping confidence limits thus re­
moving the possibility of an aberrant experiment influencing 
the statistical significance of the results.
Pathogenesis and pathology of pneumococcal infection in 
influenza C virus-infected and in normal control embryos.
The results obtained from cultures of amniotic fluid 
and heart blood and the microscopic observations of the 
respiratory tract in 3 consecutive experiments are presented 
in Table 11. Previous observations had shown that with ap­
proximately 1000 pneumococci in the inoculum of strain I 161 
infection of the amniotic fluid was uniformly established at 
24 hours. At this time blood cultures were negative and no 
inflammatory reactions had developed in the upper and lower 
respiratory tract. For these reasons embryos were sacrificed 
at the 48, 72 and 96-hour intervals.
48 Hours-combined infection. In 17 embryos amniotic
fluid cultures were positive in each, heart blood cultures
were positive in 13, none had sinusitis and five of those
with blood stream invasion had evidence of early purulent
inflammatory reaction in the bronchi and or alveolar ducts.
No lesions were found in the remaining nine with positive 
blood cultures.
Table 11. Pathogenesis and Pathology of Pneumococcal Infection in 14-Day Embryo­
nated Eggs with and without Established Influenza C virus Infection: 
The Distribution of Pneumococci and Lesions in the Respiratory Tract.
Hours after Inoculation with D.pneumoniae Cumulative
Exp, 48 72 96 at 96 hours
No. No. Am. Bl. Sin, Pn. No. Am. Bl. Sin. Pn. No. Am. Bl. Sin. Pn. No. Am. Bl. Sin. Pn.
Infl. 1 5 5 5 0 3 6 6 3 1 2 5 4 3 1 1 16 15 11 2 6
C 2 6 6 6 0 2 6 4 1 1 2 5 3 0 0 0 17 13 7 1 4
plus 3 6 6 2 0 0 6 5 2 1 2 3 2 2 1 1 15 13 6 2 3
Total 17 17 13 0 5 18 15 6 3 6 13 9 5 2 2 48 41 24 5 13
Percent
, Invaded 76 33 31 50
Pneumo- 1 6 4 0 0 0 6 6 3 3 1 4 2 1 0 1 16 12 4 3 2
coccus 2 6 4 0 0 0 6 3 1 0 1 1 1 1 0 1 13 8 2 0 2
only 3 6 1 1 0 0 6 2 1 0 0 6 1 1 0 1 18 4 3 0 1
Total 18 9 1 0 0 18 11 5 3 2 11 4 3 0 3 47 24 9 3 5
Percent
Invaded 5.5 28 27 19
No. = number of surviving embryos sacrificed for study
Am. = number of positive amniotic fluid cultures
Bl. = number of positive heart blood cultures
Sin. = number of embryos with purulent sinusitis
Pn. = number of embryos with purulent pneumonitis
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Pneumococcus only. Amniotic fluid cultures were positive 
in 9 of 18 embryos. Of these, a positive blood culture was 
obtained from one only in which no inflammatory lesions were 
present.
Comment. At 48 hours pneumococci have continued to grow 
in the amniotic fluid of each of the embryos surviving the 
combined infection while pneumococci are no longer present 
in this site in one-half of the surviving controls without 
virus infection. Invasion of the embryo by pneumococci was en­
countered in 13 of 17 or 76 percent in the combined infection 
and in 1 of 18 or 5.5 percent of embryos surviving infection 
with pneumococci only. Normal embryos appear to possess a 
much more effective defense against invasion by pneumococci 
during the first 48 hours following inoculation than do those 
with an established Influenza C virus infection.
72 Hours-combined infection. Of 18 surviving embryos 
cultures of amniotic fluid were positive in 15. Heart blood 
cultures were positive in 6 of the 15 with positive amniotic 
fluid cultures. Of the 6 with positive blood cultures 3 had 
sinusitis (Figure 6 ) 6 had pneumonitis (Figure 7) of which 3 
had both sinusitis and pneumonitis.
Pneumococcus only. Amniotic fluid cultures were positive 
in 11 of 18. Positive blood cultures were obtained from 5 of 
the 11 of which three had sinusitis and two had pneumonitis. 
Both sinusitis and pneumonitis was present in one.
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FIGURE 6
Sinusitis, combined infection 72 hours after inoculation 
with EL pneumoniae strain I 161. Cranial sinus with purulent 
exudate. H & E. X25
FIGURE 6
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FIGURE 7
Pneumonitis, combined infection 72 hours after inocula­
tion with D. pneumoniae strain I 161. Inflammatory exudate 
consists chiefly of polymorphonuclear leukocytes.
H & E. X25
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FIGURE 7
rijS?a
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Comment. At 72 hours pneumococci could not be cultured 
from the amniotic fluid of 3 of 18 with the combined infection 
and from 7 of 18 inoculated with pneumococci only. Invasion 
of the blood stream occurred in 6 of 18 or 33 percent with 
combined infection and in 5 of 18 or 28 percent of those sur­
viving infection with pneumococci only. At 72 hours the dif­
ference in the incidence of susceptibility to invasion in the 
surviving embryos in combined and infection with pneumococci 
only is much less marked than in those surviving 48 hours after 
inoculation with the bacterial component. The established 
virus infection exerts an accelerating effect on the patho­
genesis of pneumococcal disease.
96 Hours-combined infection. From 13 surviving embryos 
positive amniotic fluid cultures were obtained from nine.
Heart blood cultures were positive in five of which two had 
sinusitis, two had pneumonitis of which one had both sinusitis 
and pneumonitis.
Pneumococcus only. From 11 surviving embryos 4 positive 
amniotic fluid cultures were obtained. Heart blood cultures 
were positive in three of which none had sinusitis and two had 
pneumonitis.
Comment. At 96 hours the incidence of pneumococcal in­
vasion in the combined infection was 5 of 13 or 31 percent 
and 3 of 11 or 27 percent following inoculation with pneumo­
cocci only.
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The cumulative total for evidence of pneumococcal invasion 
of surviving embryos for the combined infection is 24 of 48 or 
50 percent and for infection with pneumococci only 9 of 47 or 
19 percent.
The inflammatory reaction in the paranasal sinuses, the 
bronchi, alveolar ducts and alveolar spaces is essentially the 
same in embryos with combined infection and those with pneumo­
cocci only. It consists chiefly of the accumulation of poly­
morphonuclear leukocytes among which relatively few mononuclears 
are present. At the 48 and 72-hour intervals the leukocytes 
are well preserved and relatively few of them have phagocytized 
one or two recognizable diplococci. An occasional extra­
cellular diplococcus is encountered at 48 hours but are not 
present at 72 or 96 hours. At 96 hours the inflammatory exudate 
appears to be resolving. Cellular outlines are indistinct, 
the cytoplasm is granular and stains poorly. Evidence of the 
effect of the virus is detectable at each of the intervals.
The epithelium of the upper and lower respiratory tract shows 
retardation in development in that most of the cells are 
cuboidal with only a few foci of ciliated columnar cells. In 
the normal controls the epithelial lining is composed of a 
predominance of ciliated columnar cells. There appears to be 
no marked difference in the extent and severity of the in­
flammatory response between the combined process and that 
caused by pneumococci only. Most of the reaction in either
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type seems to be brought about by pneumococcal invasion. Either 
relatively few bacteria incite a prompt vigorous mobilization 
of leukocytes or these cells are exceedingly efficient in phago- 
cytizing pneumococci within a short time, presumably between 24 
and 48 hours after inoculation.
Ik form induction studies (in vitro).
It was reported by Madoff and Dienes (1958) that L forma­
tion of pneumococci could be induced only at very low concentra­
tions of penicillin. Therefore, experiments were conducted at 
penicillin concentrations of 0.1 to 1.0 units per ml of culture 
medium. Fourteen pneumococcus strains representing serologic 
pools A through E were cultured for L form colonies. Luxuriant 
growth of classical colony morphology was noted within 18-24 
hours of incubation on control L form media without penicillin. 
Clearly demarcated zones of inhibition were visible at 24 hours 
about the troughs containing penicillin. Colonies were ex­
tremely small in the "swarm" areas at the periphery of the zone 
of inhibition. With a number of strains there was some smooth 
colony dissociation in which there developed rough (R) outbursts 
at certain points on the periphery of smooth colonies. Inter­
mediate colony types were also noted which did not closely 
resemble classical parent colony morphology on the control media. 
Transfers of "swarm" areas or suspected L form-like colonies 
made to fresh L form media with penicillin resulted in either
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the same colony type or no growth was observed. Because Mauney 
(1966) reported typical L form fried-egg colony appearance after 
the first few transfers; repeated transfers were made. No 
apparent reason can be given for failure to induce L formation 
with the strains studied, other than the fact that considerable 
variation in the successful isolation of L forms from pneumococci 
has been reported previously (Madoff and Dienes, 1958).
Induction of L forms was also attempted using higher con­
centrations of penicillin (100, 500 and 1000 units per trough). 
Wide zones of inhibition were noted but there was no evidence 
of "swarm" areas or L form-like colonies after 7 days of incu­
bation.
Eight strains including I 161 and Ruiz were used in ex­
periments designed to induce L formation from protoplasts as 
reported by Mauney (1966). Microscopic examination of stained 
smears of pneumococci incubated in a phosphate buffer-sucrose 
lytic system medium confirmed that the removal of cell wall 
material was evident in the spherical and pleomorphic cellular 
appearance of the pneumococci. Cultures made from aliquots 
sampled from this system showed good growth at 24 hours on L 
form media containing penicillin at concentrations of 0.18 to
0.20 units/ml. The cultures were examined at intervals up to 
5 days for the appearance of classical colonies giving rise to 
L colonies. It has been reported (Mauney, 1966) that only
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small numbers of L colonies have been recovered from pneumo­
cocci cultured in lytic system medium.
L form induction studies (in vivo).
Cultures of the amniotic fluid of nearly all of the em- 
bryonated eggs inoculated with 3.8 x 10^ pneumococci strain I 
161 were positive for pneumococci at 18-24 hours. Heart blood 
from 4 of 11 surviving embryos at 96 hours was positive for 
classical pneumococci; however, simultaneous culture on L form 
media with penicillin did not reveal the presence of colony 
types other than those of classical pneumococci. No pneumococci 
or L forms were recovered from the remaining living embryos. 
Pneumococci but no L forms were recovered from embryos which 
died during the course of the experiment.
The survival rate at 72 hours was found to be highest in 
15-day embryos receiving a pre-inoculation dose of 10 to 100 
units of penicillin. Additional experiments were undertaken 
using these two concentrations of penicillin. Of fifty-six 
15-day embryonated eggs, inoculated into the amnion with 1.2 
x 10^ - pneumococci (I 161) per embryo, 24 survived 72 hours 
after penicillin administration. Each of the surviving embryos 
was sacrificed and heart blood cultured for L forms and clas­
sical pneumococci. Only 5 of 24 were positive for pneumococci 
and no L forms were recovered. No L forms were recovered from 
the 19 remaining live embryos. Amniotic fluid from embryos
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which died during the course of the experiment was found 
positive for pneumococci but no L forms were encountered.
Each of ninety-six 15-day embryonated eggs was inocu-
p
lated on the CAM with 5 x 10 pneumococci (I 161). After 
18 hours the amniotic fluid of 65 (67.7 percent) was posi­
tive for pneumococci by culture. Of 31 surviving embryos 
sacrificed at 24 hours after penicillin administration, four 
were positive for pnoumococci when heart blood was cultured. 
The colony morphology appeared rough in two of the four 
cultures. On L form media classical pneumococcal colonies 
grew out. No L forms developed following repeated transfers 
to fresh L form media. Of 27 surviving embryos at 48 hours 
after penicillin administration only 2 positive heart blood 
cultures were obtained. The development of L forms did not 
take place.
DISCUSSION
It is noteworthy that a uniformly high cumulative mor­
tality rate resulted following amniotic inoculation of 15- 
day embryos with 8 of the 10 strains tested regardless of 
their origin. Strains isolated from routine throat cultures 
were found to be just as virulent as those obtained from blood 
or spinal fluid. Only two strains, I 151 and Ruiz, produced 
considerably lower rates and these were the only ones with 
which satisfactory LD^q values could be established. Follow­
ing infection of 15-day embryos with these two strains most 
of the deaths occurred between 48 and 72 instead of between 
24 and 48 hours in 15-day embryos infected with the other 
strains. The eventual cumulative mortality rates for strains 
I 161 and Ruiz for 15-day embryos were the same as those for 
the other strains in 15-day embryos. This suggests that the 
strains of lower virulence proliferate more slowly and that 
the number of pneumococci is critical in effecting the fatal 
outcome. Furthermore, the age-related resistance of the 
chick embryo to infection with pneumococci is evident as has 
been demonstrated for a great variety of infectious agents 
(Buddingh, 1970).
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In general the mortality; rates obtained in chicle embryos 
are within the range of those following intraperitonea1 in­
jection of mice. Relatively few strains are encountered with 
which infection cannot be brought about. Once this is es­
tablished a high mortality rate results. Thus most pneumo­
coccal strains, regardless of type specificity and site of 
origin, are of high potential virulence. For example, strain 
I 161 (Type XIII) was isolated from a routine throat culture; 
strain Ruiz (Type XIX) was isolated from the blood of a case 
of purulent meningitis. When sporadic: disease in man occurs, 
lowered host resistance rather than enhancement in virulence 
of the bacteria plays the predominant role. Only in epidemics 
of pneumonia in which a single pneumococcal type is the 
causative agent is it likely that enhancement of virulence 
becomes a prominent factor.
The potential high virulence of pneumococci is reflected 
in the behavior of strains I 161 and Ruiz for which LD^q 
values were determined following combined and single infection. 
With strain I 161 no statistically significant differences 
could be ascertained in the LD^q values based on the cumulative 
mortality rates. A significant difference in favor of the 
combined infection could be noted in the slope of the percent 
mortality curve during the first 24 hours following inoculation. 
After this period the rate of increase in percent mortality
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as reflected in the slope of the curve following combined 
and single infection was approximately the same. With strain 
Ruiz, on the other hand, the difference between an LD50 value 
of 4 for the combined and a value of 40 for the single infec­
tion is statistically significant.
It is difficult to conclude on the* basis of the low LD50 
values for both combined and single infections that an estab­
lished Influenza C virus greatly enhances the virulence of 
superimposed pneumococci in experimental infection of embryo- 
nated eggs. Although the 10-fold differences in LD^q values 
for the combined and single infection with strain Ruiz are 
statistically significant, this is in sharp distinction to 
the 4 and 5 logarithm greater value for the single than the 
combined infection with Hemophilus influenzae.
Comparison of the in vitro growth curves of strain I 161 
revealed a faster rate in amniotic fluid from virus-infected 
than in fluid from normal controls. During the first 8 to 10 
hours during which the logarithmic phase of the growth took 
place there were considerably greater numbers of pneumococci 
in the fluid of the virus-infected embryos. If it can be as­
sumed that pneumococcal growth rate in the amniotic fluid of 
the intact embryo approximates that in fluid in vitro, it is 
evident that the greater mortality occurring in the combined 
infection during the first 24 hours can be attributed to the
significantly greater number of bacteria. In the single 
infectious process there very likely is a lag phase in the 
in vivo growth curve as observed in vitro and this could ac­
count for the delay in the occurrence of deaths. Under con­
ditions of in vitro growth pneumococci behave quite differently 
from H. influenzae. Hemophilus will not grow in amniotic fluid 
only but requires components provided by the addition of 
Levinthal's broth or minimum essential medium. This must re­
present its requirement for X and V as well as other essential 
growth factors which quite likely are present at minimal levels 
in the fluid of the intact embryo. Pneumococci are evidently 
not this fastidious so that their ready adaptation to growth 
in the intact embryo represents an important factor in their 
marked pathogenicity as compared to H. influenzae.
The pathological lesions produced in the chick embryo 
by pneumococci in combined and single infection are quite 
similar to those encountered with H.' influenzae. The reactions 
are restricted to the upper and lower respiratory tract and 
consist of the exudation of predominantly polymorphonuclear 
leukocytes in response to the localization of pneumococci in 
the paranasal sinuses, the bronchi, alveolar ducts and al­
veolar spaces. As with Hemophilus the reactions in the com­
bined process are more frequent, extensive and severe. Blood 
stream invasion occurs more frequently in the combined than
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in the single infection. It is not clear as to whether bac­
teremia results from the extension from the local lesions or 
that direct invasion without localization occurs. There were 
several instances where bacteremia without the development of 
inflammatory response took place indicating that both invasion 
routes are available. However, bacteremia was present in each 
embryo with inflammatory lesions and in these the pneumococci 
were most likely transported throughout the respiratory tract 
in amniotic fluid aspirated by respiratory movements of the 
embryo.
From all appearances the inflammatory reactions were 
self-limiting in nature. It was somewhat surprising to find 
few if any pneumococci among the leukocytes which seemed to 
possess an efficient phagocytic capacity. The progression in 
the nature of the inflammation from early exudation of active 
healthy cells to eventual disintegration and resolution was 
in clear evidence. It might be concluded that were it not for 
other factors the embryonic host would have recovered from 
the infection. Although this was not demonstrated, the cause 
of embryonic death was very likely primarily due to the ac­
cumulation of toxic substances derived from the pneumococci. 
Further studies will be required to solve this problem. In 
this regard the much greater survival rate following Hemophilus
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infection would seem to emphasize the marked toxicity of 
pneumococci for the chick embryo and the human host. Whether 
or not these factors are predominantly derived from the cap­
sule, cell wall or somatic portion of the microorganism pre­
sents a problem for further investigation.
It is apparent that infection of the chick embryo is not 
conducive to the development of L forms of the pneumococcus.
If this can be achieved, other conditions than these provided 
by the normal chick embryo must be produced. The potentiali­
ties of the method, however, have not been exhausted and de­
serve further exploration.
In spite of the presumed effectiveness of antibiotic 
therapy pneumococcal infection still comprises one of the 
leading causes of morbidity and mortality in man. Of special 
concern is the greater susceptibility of the elderly and de­
bilitated either as individuals or in segregated groups as 
well as the increased mortality rate during epidemic respira­
tory viral infections, particularly influenza. Considerable 
ignorance still exists regarding the factors and mechanisms 
which under these circumstances relate to the virulence of the 
parasite on the one hand and th£ susceptibility or resistance 
of the host and/or host population on the other.
The studies described here represent only preliminary 
excursions into the problems presented by pneumococcal infec­
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tion with or without recognizable disease. The apparent age- 
related resistance of the chick embryo to pneumococcal infec­
tion should provide a wide spectrum ranging from complete 
susceptibility to complete resistance of an experimental host 
for an elucidation of the dynamics of this infectious process. 
Further studies should be concerned with the nature of yet 
unidentified toxic substances produced during infection which 
apparently play a predominant role in the lethal outcome.
These substances may not be demonstrable or present in artifi­
cial culture but may very likely be derived from the inter­
action between the living parasite and host. The factors 
which influence the increased susceptibility of the influenza 
virus-infected embryo require closer scrutiny. It would be 
of considerable interest to know whether the slight retardation 
of embryonic development induced by virus infection reflects 
age-related resistance or that the increased susceptibility to 
lethal infection reflects primarily bacterial population dyna­
mics as has demonstrated for H. influenzae. The marked con­
trast in behavior of these two potential bacterial pathogens 
under similar experimental conditions may provide clues to a 
better understanding of the pathogenesis of acute respiratory 
infection.
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